Development of Mixed Th1/Th2 Type Immune Response and Protection Against Mycobacterium tuberculosis After Rectal or Subcutaneous Immunization of Newborn and Adult Mice with Mycobacterium bovis BCG

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Scandinavian Journal of Immunology

• Publication date

  2002-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1365-3083.2002.01049.xPMID 11940236
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Exclusive Th2 Primary Effector Function in Spleens but Mixed Th1/Th2 Function in Lymph Nodes of Murine Neonates1

  2000cited by this paper
• CD4+ T-Cell Subsets That Mediate Immunological Memory to Mycobacterium tuberculosis Infection in Mice

  2000cited by this paper
• Mycobacterium bovis BCG Induces Similar Immune Responses and Protection by Rectal and Parenteral Immunization Routes

  2000cited by this paper
• Early Emergence of CD8+ T Cells Primed for Production of Type 1 Cytokines in the Lungs of Mycobacterium tuberculosis-Infected Mice

  1999cited by this paper
• Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guérin vaccination.

  1999cited by this paper
• Vaccinated Mice Remain More Susceptible to Mycobacterium tuberculosis Infection Initiated via the Respiratory Route than via the Intravenous Route

  1999cited by this paper
• Outbreak of viral hepatitis B in a rural community in India linked to inadequately sterilized needles and syringes.

  1998cited by this paper
• Mycobacterial Dose Defines the Th1/Th2 Nature of the Immune Response Independently of Whether Immunization Is Administered by the Intravenous, Subcutaneous, or Intradermal Route

  1998cited by this paper
• Induction of humoral and cellular immunity against influenza virus by immunization of newborn mice with a plasmid bearing a hemagglutinin gene.

  1997cited by this paper
• DNA immunization circumvents deficient induction of T helper type 1 and cytotoxic T lymphocyte responses in neonates and during early life.

  1997cited by this paper
• Induction of TH1 and TH2 Immunity in Neonatal Mice

  1996cited by this paper
• Induction of Protective CTL Responses in Newborn Mice by a Murine Retrovirus

  1996cited by this paper
• Partial correction of the TH2/TH1 imbalance in neonatal murine responses to vaccine antigens through selective adjuvant effects

  1996cited by this paper
• Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th2‐biased pattern which persists after adult boosting

  1996cited by this paper
• The protective immune response to Mycobacterium tuberculosis.

  1995cited by this paper
• Distinct phenotypes of antigen-selected CD8 T cells emerge at different stages of an in vivo immune response.

  1995cited by this paper
• The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature.

  1995cited by this paper
• Turnover of naive- and memory-phenotype T cells

  1994cited by this paper
• Evolution of CD4 T-cell subsets following infection of naive and memory immune mice with Mycobacterium tuberculosis

  1994cited by this paper
• The role of TNF-alpha in T-cell-mediated inflammation depends on the Th1/Th2 cytokine balance.

  1994cited by this paper
• Developmental regulation of IL-4, IL-2, and IFN-gamma production by murine peripheral T lymphocytes.

  1993cited by this paper
• An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

  1993cited by this paper
• Identification of a Mycobacterium bovis BCG 45/47-kilodalton antigen complex, an immunodominant target for antibody response after immunization with living bacteria

  1993cited by this paper
• The mucosal immune system: from fundamental concepts to vaccine development.

  1992cited by this paper
• Decreased production of interferon-gamma by human neonatal cells. Intrinsic and regulatory deficiencies.

  1986cited by this paper
• The effects of dispersed or surface grown cultures, manufacture and control methods on BCG standardization.

  1986cited by this paper
• Impaired production of gamma-interferon by newborn cells in vitro is due to a functionally immature macrophage.

  1985cited by this paper
• BCG complications. Estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics.

  1984cited by this paper

• NOD2 (Nucleotide-Binding Oligomerization Domain-Containing Protein 2)-Mediated Modulation of the Immune Response Induced by BCG (Bacillus Calmette-Guérin) Bacilli

  2025cites this paper
• Current progress in pharmacokinetic studies of vaccines: Impact of carrier, ADME and its modulation on immune responses.

  2023cites this paper
• Rectal Administration of Leishmania Cells Elicits a Specific, Th1-Associated IgG2a Response in Mice: New Perspectives for Mucosal Vaccination against Leishmaniasis, after the Repurposing of a Study on an Anti-Viral Vaccine Candidate

  2023cites this paper
• Comparison of different immunization routes on the immune responses induced by Mycobacterium tuberculosis ESAT-6/CFP-10 recombinant protein.

  2019cites this paper
• Synergy between Th1 and Th2 responses during Mycobacterium tuberculosis infection: A review of current understanding

  2019cites this paper
• Mycobacterium bovis BCG and New Vaccines for the Prevention of Tuberculosis

  2016cites this paper
• Immunization with Single Oral Dose of Alginate‐Encapsulated BCG Elicits Effective and Long‐Lasting Mucosal Immune Responses

  2015cites this paper
• B subunits of cholera toxin and thermolabile enterotoxin of Escherichia coli have similar adjuvant effect as whole molecules on rotavirus 2/6-VLP specific antibody responses and induce a Th17-like response after intrarectal immunization.

  2015cites this paper
• Poly D,L-lactide-co-glycolide (PLGA) nanoparticle-encapsulated honeybee (Apis melifera) venom promotes clearance of Salmonella enterica serovar Typhimurium infection in experimentally challenged pigs through the up-regulation of T helper type 1 specific immune responses.

  2014cites this paper
• Neonatal Vaccination with Plasmid DNA Encoding Cyn d 1 Effectively Prevents Allergic Responses in Mice

  2014cites this paper
• Rectal single dose immunization of mice with Escherichia coli O157:H7 bacterial ghosts induces efficient humoral and cellular immune responses and protects against the lethal heterologous challenge

  2012cites this paper
• Mycobacterium bovis BCG and New Vaccines against Tuberculosis

  2011cites this paper
• Boosting with mycobacterial heparin-binding haemagglutinin enhances protection of Mycobacterium bovis BCG-vaccinated newborn mice against M. tuberculosis.

  2010cites this paper
• Neonatal BCG Immunization Followed by DNAhsp65 Boosters: Highly Immunogenic but not Protective Against Tuberculosis – a Paradoxical Effect of the Vector?

  2010cites this paper
• PCEP enhances IgA mucosal immune responses in mice following different immunization routes with influenza virus antigens

  2010cites this paper
• Recombinant Mycobacterium bovis BCG as an HIV vaccine vector.

  2010cites this paper
• مقایسه اثر واکسیناسیون BCG استنشاقی با تزریق زیرپوستی بر تولید نیتریک اکساید در ماکروفاژها و میزان نهفتگی انگل در بدن موش BALB/c آلوده به لیشمانیا ماژور

  2008cites this paper
• Effect of Neonatal Sublingual Vaccination with Native or Denatured Ovalbumin and Adjuvant CpG or Cholera Toxin on Systemic and Mucosal Immunity in Mice

  2008cites this paper
• Distribution and phenotype of rotavirus‐specific B cells induced during the antigen‐driven primary response to 2/6 virus‐like particles administered by the intrarectal and the intranasal routes

  2007cites this paper
• Synthetic Toll-Like Receptor 4 Agonist Enhances Vaccine Efficacy in an Experimental Model of Toxic Shock Syndrome

  2007cites this paper
• Mycobacterium bovis BCG Substrains Confer Different Levels of Protection against Mycobacterium tuberculosis Infection in a BALB/c Model of Progressive Pulmonary Tuberculosis

  2006cites this paper
• Pulmonary Tuberculosis Infection in a BALB / c Model of Progressive Mycobacterium tuberculosis against Confer Different Levels of Protection BCG Substrains Mycobacterium bovis

  2006cites this paper
• A Combined DNA Vaccine-Prime, BCG-Boost Strategy Results in Better Protection Against Mycobacterium bovis Challenge

  2006cites this paper
• Immune Response Following Oral Immunization with BCG Encapsulated in Alginate Microspheres.

  2006cites this paper
• Similar functional activity of dendritic cells recruited to the mesenteric lymph nodes of newborn and adult mice after the rectal delivery of Mycobacterium bovis BCG.

  2006cites this paper
• Rectal Immunization with Rotavirus Virus-Like Particles Induces Systemic and Mucosal Humoral Immune Responses and Protects Mice against Rotavirus Infection

  2006cites this paper
• Vaccination of Cattle with a CpG Oligodeoxynucleotide-Formulated Mycobacterial Protein Vaccine and Mycobacterium bovis BCG Induces Levels of Protection against Bovine Tuberculosis Superior to Those Induced by Vaccination with BCG Alone

  2005cites this paper
• No Job Name

  2005cites this paper
• Tuberculose : place de la vaccination dans la maîtrise de la maladie

  2004cites this paper
• BCG vaccine modulates intestinal and systemic response to β‐lactoglobulin

  2004cites this paper
• Current and Emerging Nonsteroidal Anti-Inflammatory Therapies Targeting Specific Mechanisms in Asthma and Allergy

  2004cites this paper
• A second-generation anti TB vaccine is long overdue

  2004cites this paper
• Initiation of Lung Immunity: The Afferent Limb and the Role of Dendritic Cells

  2004cites this paper
• BCG vaccine modulates intestinal and systemic response to beta-lactoglobulin.

  2004cites this paper
• Initiation of lung immunity: the afferent limb and the role of dendritic cells.

  2004cites this paper
• Is all-cause mortality a useful epidemiological endpoint in vaccine trials? An example of BCG (Bacille-Calmette-Guerine).

  2003cites this paper
• Is all-cause mortality a useful epidemiological endpoint in vaccine trials ?

  2003cites this paper
• Tuberculosis vaccines: the past, present and future

  2002cites this paper
• Annals of Clinical Microbiology and Antimicrobials Open Access a Second-generation Anti Tb Vaccine Is Long Overdue

  year unknowncites this paper